DELFI Diagnostics
ApprovedTo study the effectiveness of our fragmentomics technology, DELFI has enrolled thousands of participants in our groundbreaking clinical trial, CASCADE-LUNG.
Founded
2019
Focus
Diagnostics
About
To study the effectiveness of our fragmentomics technology, DELFI has enrolled thousands of participants in our groundbreaking clinical trial, CASCADE-LUNG.
Funding History
2Total raised: $325M
Series B$225MForesite CapitalSep 15, 2022
Series A$100MOrbiMedMay 15, 2021
Company Info
TypePrivate
Founded2019
LocationBaltimore, United States
StageApproved
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile